Intellia Therapeutics (NTLA)
(Delayed Data from NSDQ)
$26.46 USD
+1.13 (4.46%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $26.44 -0.02 (-0.08%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-1.21 | 0.00% |
Earnings Summary
For their last quarter, Intellia Therapeutics (NTLA) reported earnings of -$1.06 per share, beating the Zacks Consensus Estimate of $-1.35 per share. This reflects a positive earnings surprise of 21.48%. Look out for NTLA's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$1.21 per share, reflecting a year-over-year increase of 13.57%.
Earnings History
Price & Consensus
Zacks News for NTLA
Kyverna (KYTX) Gets RMAT Designation for CAR T-Cell Product
NTLA: What are Zacks experts saying now?
Zacks Private Portfolio Services